The Novilase® Clinical Trial (BR-002) is an investigational research study in early-stage breast cancer. For specific inclusion/exclusion criteria visit clinicaltrials.gov (# NCT01478438) or novilase.com.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…